← FDA DRUG APPROVALS

FDA ANDA · ANDA075048

ENALAPRIL MALEATE

Sponsor: CHARTWELL RX

APPLICATION
ANDA075048
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-22
LATEST ACTION
2002-07-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 10MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 2.5MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 20MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 5MG · TABLET · ORAL

Approval history

2002-07-30Labeling · Supplement 5AP
2002-05-10Manufacturing (CMC) · Supplement 1AP
2002-04-19Manufacturing (CMC) · Supplement 3AP
2000-08-22OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →